Acute immune thrombocytopenia (ITP) in childhood: Retrospective and prospective survey in Germany

Seminars in Thrombosis and Hemostasis

Volumn 27, Issue 3, 2001, Pages 253-267

  Sutor, A H ^a   Harms, A ^a   Kaufmehl, K ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Children; Immune thrombocytopenia (ITP); Incidence; Platelet count; Side effects of treatment; Survey; Symptoms; Treatment

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN;

ADOLESCENT; AGE DISTRIBUTION; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; FATIGUE; FEMALE; FEVER; GERMANY; HEADACHE; HEALTH SURVEY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEWBORN; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; QUESTIONNAIRE; SEX RATIO; THROMBOCYTE COUNT; TREATMENT OUTCOME; VOMITING;

EID: 0034967434     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-15255     Document Type: Conference Paper

References (73)

1. Acute immune thrombocytopenia in childhood. Are we treating the platelet count?
2. Idiopathic thrombocytopenic purpura: Beyond consensus
3. Immune thrombocytopenic purpura: Why treat?
4. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methyl-prednisolone, intravenous immunoglobulin, or the combination of both
5. Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Associazione Italiana di Ematologia e Oncologia Pediatrica
6. Abklärung einer blutungsneigung
7. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines
8. Management of childhood idiopathic thrombocytopenic purpura
9. Acute autoimmune thrombocytopenia
10. Idiopathic thrombocytopenic purpura
11. Immune thrombocytopenia. A diagnostic and therapeutic problem?
12. Idiopathic thrombocytopenia, initial illness and long term follow up
13. Current controversies in the management of idiopathic thrombocytopenic purpura during childhood
14. Management of childhood idiopathic thrombocytopenic purpura
15. Investigation and treatment of immune thrombocytopenic purpura in children in Norway
16. Childhood idiopathic thrombocytopenic purpura: Report of 60 cases from Kuwait
17. Ethnicity and environment may affect the phenotype of immune thrombocytopenic purpura in children
18. Idiopathic thrombocytopenic purpura (ITP) in Ethiopian children: Clinical findings and response to therapy
19. Idiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and diagnosis in children and adults
20. Autoimmune (idiopathic) thrombocytopenic purpura
21. Use of corticosteroids and immunoglobulins in acute and chronic immune thrombocytopenia in childhood. A clinically oriented treatment concept
22. Prevalence and treatment of chronic idiopathic thrombocytopenic purpura of childhood in Sweden
23. Immune thrombocytopenic purpura in childhood in Norway: A prospective, population-based registration
24. Vitamin K deficiency bleeding (VKDB) in infancy
25. Epstein-Barr virus associated with immune thrombocytopenic purpura in childhood: A retrospective study
26. Idiopathic thrombocytopenic purpura in childhood
27. The place of intravenous immunoglobulin (IgG i.v.) therapy in thrombocytopenia
28. A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura
29. Immune thrombocytopenic purpura ITP
30. Immune thrombocytopenic purpura after recombinant hepatitis B vaccine: Retrospective study of seven cases
31. Major hemorrhage in children with idiopathic thrombocytopenic purpura: Immediate response to therapy and long-term outcome
32. Intracranial hemorrhage associated with idiopathic thrombocytopenic purpura: Report of seven patients and a meta-analysis
33. Treatment of children with immune thrombocytopenic purpura: Are we closer to resolving the dilemma?
34. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment
35. Thrombozytenzählung bei thrombozytopenie
36. Ethnicity and environment may affect the phenotype of immune thrombocytopenic purpura in children
37. Acute idiopathic thrombocytopenic purpura - Management in childhood
38. Characteristic generated alterations of autoantibody patterns in idiopathic thrombocytopenic purpura
39. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia
40. Hämorrhagische diathese bei störungen der primären hämostase
41. Difficulties in determining prophylactic transfusion thresholds of platelets in leukemia patients
42. Treatment of acute idiopathic thrombocytopenic purpura in children. A retrospective evaluation of 120 cases
43. Treatment dilemma in childhood idiopathic thrombocytopenic purpura
44. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: Results of a survey of practicing pediatric hematology/oncology specialists
45. Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G
46. Adverse reactions after ITP treatment with high dose of intravenous Ig
47. Intravenous anti-D treatment of immune thrombocytopenic purpura: Experience in 272 patients
48. Corticosteroid prophylaxis for neurologic complications of intravenous immunoglobulin G therapy in childhood immune thrombocytopenic purpura
49. Aseptische meningitis nach i.v. immunoglobulingabe
50. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients
51. Drop of leukocytes after treatment with immunoglobulins in children with acute immune thrombocytopenia (ITP)
52. Neutropenia as a complication of intravenous immunoglobulin (IVIG) therapy in children with immune thrombocytopenic purpura: Common and non-alarming
53. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
54. Acute idiopathic thrombocytopenic purpura-management in childhood
55. Intravenous immunoglobulin therapy and renal dysfunction
56. Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease
57. Effect of high-dose immunoglobulin therapy on blood rheology
58. Acute renal failure complicating high-dose intravenous immunoglobulin therapy for acquired haemophilia
59. Hemiplegia as a complication of treatment of childhood immune thrombocytopenic purpura with intravenously administered immunoglobulin
60. Cardiac rhythm abnormalities during intravenous immunoglobulin G infusion for treatment of thrombocytopenia
61. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura
62. Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura
63. Effect of glucocorticoids, E. coli and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia
64. Oral megadose methylprednisolone versus intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura
65. Guidelines for management of idiopathic thrombocytopenic purpura
66. A multicenter European trial of intravenous immune globulin in immune thrombocytopenic purpura in childhood
67. Idiopathic thrombocytopenic purpura: Reasons to resolve the chaos
68. Idiopathic thrombocytopenic purpura: A guideline for diagnosis and management of children and adults
69. Chronic idiopathic thrombocytopenic purpura. Current therapy concept and introduction to pathophysiologic, clinical and diagnostic aspects
70. Long-term follow-up of autoimmune thrombocytopenic purpura (ATP) patients submitted to splenectomy
71. Epidemiology of childhood immune thrombocytopenic purpura in a defined area in Europe, and rational and profile of a intercontinental ITP registry
72. Akute postinfektiöse immunthrombozytopenie (ITP) im kindesalter